Drugmaker Sanofi Friday said its animal health division Merial has completed acquisition of the animal health division of Dosch Pharmaceuticals to enter India's growing animal health market.
The signing of a binding agreement, leading up to the acquisition, was announced in December last year.
Merial and Dosch have now completed all regulatory approvals required for the closing of the acquisition, a company release said here.
Dosch, an India-based diversified pharmaceutical company, is a manufacturer of veterinary pharmaceuticals and exporter of bulk drugs and formulations.
The acquired business, now the animal health division of Sanofi Synthelabo India, will commence marketing Dosch's 86 animal health products and 50 brands for ruminants, poultry and companion animals.